Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide and Diet in Mild Crohn's Disease
NCT06774079Phase 4Active, not recruiting
- Sponsor
- University of Miami
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in Crohn's disease, sponsored by University of Miami. Started Mar 2025; status: active, not recruiting.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06774079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06774079.